Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Rite Aid stock fell as much as 18.5% in morning trading after a Bloomberg report that the FTC is "worried" about the details of Walgreens planned buyout of its smaller rival. It's since pared about half of those losses.
(function () { var attempt = 0, init = function(){ if (window.pym) { var pymParent = new pym.Parent("g-right-aid-01-box", "https://graphics.axios.com/2017-01-20-right-aid/right-aid-01.html", {}); } else if (attempt++ & 40) { setTimeout(init, 50); } }; init(); })();
Data: Money.net; Chart: Andrew Witherspoon / Axios
Walgreens had planned to sell hundreds of its stores to regional pharmacy chain Fred's, but reports are that the FTC may not see these divestitures as bold enough to avoid antitrust concerns.
Why it matters: The Obama Administration ramped up antitrust oversight and one of the big question marks of the Trump Administration is whether it will get tough on mergers or take a more traditional Republican stance. The Walgreens-Rite Aid merger could be an important clue in this puzzle.